Gene · 4939
Papers2,192
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 2,192
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sample processing and single cell RNA-sequencing of peripheral blood immune cells from COVID-19 patients. | STAR Protoc | 2021 | 34002169 | PubTator, text mining | PubMed |
| New insights into human immunity from ancient genomics. | Curr Opin Immunol | 2021 | 33992907 | PubTator, text mining | PubMed |
| EnRank: An Ensemble Method to Detect Pulmonary Hypertension Biomarkers Based on Feature Selection and Machine Learning Models. | Front Genet | 2021 | 33986767 | PubTator, text mining | PubMed |
| Genes and pathways monotonically dysregulated during progression from normal through leukoplakia to gingivo-buccal oral cancer. | NPJ Genom Med | 2021 | 33980865 | PubTator, text mining | PubMed |
| Genetic predisposition in the 2'-5'A pathway in the development of type 1 diabetes: potential contribution to dysregulation of innate antiviral immunity. | Diabetologia | 2021 | 33973017 | PubTator, text mining | PubMed |
| Circular RNA circitga7 accelerates glioma progression via miR-34a-5p/VEGFA axis. | Aging (Albany NY) | 2021 | 33962397 | PubTator, text mining | PubMed |
| Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. | Cell | 2021 | 33961781 | PubTator, text mining | PubMed |
| Downregulation of microRNA‑221 facilitates H1N1 influenza A virus replication through suppression of type‑IFN response by targeting the SOCS1/NF‑κB pathway. | Mol Med Rep | 2021 | 33955508 | PubTator, text mining | PubMed |
| Experimental and natural evidence of SARS-CoV-2-infection-induced activation of type I interferon responses. | iScience | 2021 | 33937724 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing Analysis of the Immunometabolic Rewiring and Immunopathogenesis of Coronavirus Disease 2019. | Front Immunol | 2021 | 33936072 | PubTator, text mining | PubMed |
| Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection. | Arch Virol | 2021 | 33934196 | PubTator, text mining | PubMed |
| Proteome study of cutaneous lupus erythematosus (CLE) and dermatomyositis skin lesions reveals IL-16 is differentially upregulated in CLE. | Arthritis Res Ther | 2021 | 33931094 | PubTator, text mining | PubMed |
| (E)-Guggulsterone Inhibits Dengue Virus Replication by Upregulating Antiviral Interferon Responses through the Induction of Heme Oxygenase-1 Expression. | Viruses | 2021 | 33924157 | PubTator, text mining | PubMed |
| Functional Interfaces, Biological Pathways, and Regulations of Interferon-Related DNA Damage Resistance Signature (IRDS) Genes. | Biomolecules | 2021 | 33922087 | PubTator, text mining | PubMed |
| Characterization of Type I Interferon-Associated Chemokines and Cytokines in Lacrimal Glands of Nonobese Diabetic Mice. | Int J Mol Sci | 2021 | 33916486 | PubTator, text mining | PubMed |
| SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery. | Cell Rep | 2021 | 33905739 | PubTator, text mining | PubMed |
| Positive natural selection in primate genes of the type I interferon response. | BMC Ecol Evol | 2021 | 33902453 | PubTator, text mining | PubMed |
| Comprehensive at-arrival transcriptomic analysis of post-weaned beef cattle uncovers type I interferon and antiviral mechanisms associated with bovine respiratory disease mortality. | PLoS One | 2021 | 33901263 | PubTator, text mining | PubMed |
| Identification of key genes and pathways in discoid lupus skin via bioinformatics analysis. | Medicine (Baltimore) | 2021 | 33879674 | PubTator, text mining | PubMed |
| Multisystem inflammation and susceptibility to viral infections in human ZNFX1 deficiency. | J Allergy Clin Immunol | 2021 | 33872655 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4939/papers?page=48